CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

42.32 USD
+1.95 (+4.83%)
Last:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • In the past year CXT was profitable.
  • CXT had a positive operating cash flow in the past year.
  • In the past 5 years CXT has always been profitable.
  • In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT has a Return On Assets of 4.66%. This is in the better half of the industry: CXT outperforms 70.16% of its industry peers.
  • CXT has a Return On Equity of 11.58%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
  • With a decent Return On Invested Capital value of 7.93%, CXT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.35%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT's Profit Margin of 8.76% is fine compared to the rest of the industry. CXT outperforms 79.84% of its industry peers.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • With an excellent Operating Margin value of 15.91%, CXT belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
  • CXT's Operating Margin has improved in the last couple of years.
  • CXT has a better Gross Margin (42.48%) than 72.58% of its industry peers.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
  • CXT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CXT has less shares outstanding
  • The debt/assets ratio for CXT is higher compared to a year ago.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CXT has a worse Altman-Z score (1.83) than 64.52% of its industry peers.
  • The Debt to FCF ratio of CXT is 5.75, which is a neutral value as it means it would take CXT, 5.75 years of fcf income to pay off all of its debts.
  • CXT has a Debt to FCF ratio (5.75) which is comparable to the rest of the industry.
  • CXT has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • CXT has a worse Debt to Equity ratio (0.91) than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.83
ROIC/WACC0.85
WACC9.33%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • CXT has a Current Ratio of 1.50. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT has a worse Current ratio (1.50) than 76.61% of its industry peers.
  • CXT has a Quick Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.20, CXT is not doing good in the industry: 69.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.92%.
  • CXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.12% yearly.
  • CXT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.43%.
  • The Revenue has been decreasing by -9.71% on average over the past years.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • Based on estimates for the next years, CXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.32% on average per year.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.42, the valuation of CXT can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 93.55% of the companies listed in the same industry.
  • CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • CXT is valuated reasonably with a Price/Forward Earnings ratio of 9.81.
  • Based on the Price/Forward Earnings ratio, CXT is valued cheaply inside the industry as 91.94% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (22.42), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.42
Fwd PE 9.81
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.32% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.26
EV/EBITDA 8.35
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)9.3
EPS Next 2Y8.32%
EPS Next 3YN/A

6

5. CXT Dividend Analysis

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.73%.
  • Compared to an average industry Dividend Yield of 0.46, CXT pays a better dividend. On top of this CXT pays more dividend than 93.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 26.88% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP26.88%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (3/23/2026, 11:39:17 AM)

42.32

+1.95 (+4.83%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change4.91%
Market Cap2.43B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (115.88%)
Short Float %13.81%
Short Ratio9.48
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-3.98%
EPS NQ rev (1m)-15.7%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-8.31%
Revenue NQ rev (1m)-2.07%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 10.42
Fwd PE 9.81
P/S 1.47
P/FCF 12.26
P/OCF 10.07
P/B 1.94
P/tB N/A
EV/EBITDA 8.35
EPS(TTM)4.06
EY9.59%
EPS(NY)4.32
Fwd EY10.2%
FCF(TTM)3.45
FCFY8.16%
OCF(TTM)4.2
OCFY9.93%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.65
PEG (5Y)9.3
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.83
F-Score4
WACC9.33%
ROIC/WACC0.85
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 26.88%.